An Open-Label Study to Evaluate the Effect of Age Upon the Pharmacokinetics of Androxal
Phase of Trial: Phase I
Latest Information Update: 20 Oct 2015
Price : $35 *
At a glance
- Drugs Enclomifene (Primary)
- Indications Hypogonadism; Male infertility; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Repros Therapeutics
- 30 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 07 Aug 2014 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 27 Jun 2014 New trial record